Julia Steinke, MD
Pediatric Nephrology · Houston, TXNPI 1083622807
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 67.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $301, 5.0 times the $60 reported in 2019.
Across 8 payments — averaging $84.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$454
- Apellis Pharmaceuticals, Inc.$126
- Takeda Pharmaceuticals U.S.A., Inc.$47
- Silvergate Pharmaceuticals, Inc.$31
- Ultragenyx Pharmaceutical Inc.$17
Across 9 payments — averaging $4730.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$24K
- Akebia Therapeutics Inc$19K
What the payments were for
- Consulting fees$17526%
- Speaking & faculty fees$25037%
- Food & beverage$24937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $454 |
| Apellis Pharmaceuticals, Inc. | 1 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Silvergate Pharmaceuticals, Inc. | 1 | $31 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTOMIRIS$175
How this compares
$674 in reported general payments places this provider in the 65th percentile of 61 pediatric nephrology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric nephrology in Houston
- Mini MichaelHouston$25K
- Rita SwinfordHouston$25K
- Ewa ElenbergHouston$16K
- Joshua SamuelsHouston$2K
- Eileen BrewerHouston$678
- Joseph AngeloHouston$456
- Jennifer KinneyHouston$330
- Sahar SiddiquiHouston$300
- Michael BraunHouston$276
- Shweta ShahHouston$233
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.